$1.06
Price
$56M
Market Cap
—
P/E Ratio
-0.7
Forward P/E
$-1.59
EPS (TTM)
—
Dividend Yield
$129M
Cash
$1M
Total Debt
53M
Shares Out
$0.81
$1.84
52-Week Range
Institutional Ownership of PMV PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for PMV PHARMACEUTICALS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2022-Q2 | |||||
| SELL | EXIT | — | — | $13.89 | |
| 2021-Q2 | |||||
| SELL | -14.2% | 1.8M | $61M | $33.72 | |
| 2021-Q1 | |||||
| SELL | -11.8% | 2.1M | $69M | $39.58 | |
| 2020-Q4 | |||||
| SELL | -10.5% | 2.4M | $145M | $35.66 | |
| 2020-Q3 | |||||
| BUY | NEW | 2.6M | $94M | $37.51 | |
Insider Trading for PMV PHARMACEUTICALS INC
6 Months Insider Sentiment
Buy $0
Sell $2.4M
0
Buys
2
Sells
-2.4M
Net
0
Grants
Largest
$1.5M
LLC
$900K
LLC
$302K
Mack
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 27, 2025 | David Henry Mack | President and CEO | EXERCISE | 220.6K | $1.37 | $302K |
| Oct 23, 2025 | ORBIMED ADVISORS LLC | 10% Owner | SELL | 1.00M | $1.52 | $1.5M |
| Sep 10, 2025 | ORBIMED ADVISORS LLC | 10% Owner | SELL | 500.0K | $1.80 | $900K |